First Irish prostate cancer patients benefit from new non-invasive therapy
Briefly

Focal therapy utilizes high intensity focused ultrasound to induce cell death while protecting surrounding tissues, significantly reducing risks associated with traditional cancer treatments.
Focal therapy provides patients the highest chance to preserve ejaculation post-treatment, distinguishing it from other less targeted treatment options.
Mr. Inder emphasized that prostate cancer is the most prevalent cancer in men in Ireland. With around 4,000 men affected yearly, new technologies for better outcomes are crucial.
Recovery following focal therapy is generally swift, as most patients return to work within two weeks, allowing for a better quality of life.
Read at Irish Independent
[
|
]